Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0134
Source ID: NCT01991574
Associated Drug: Calcium Acetate
Title: Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Healthy|Chronic Kidney Diseases
Interventions: DRUG: Calcium acetate|DIETARY_SUPPLEMENT: Iron Hydroxide Adipate|DRUG: Placebo
Outcome Measures: Primary: urinary phosphate, To determine if the ingestion of ferric hydroxide adipate with food induces a reduction in urinary phosphate concentration, compared with the administration of placebo plus the same food on a different occasion., 9 hours | Secondary: iron absorption, iron absorption from the ferric hydroxide adipate treatment will be determined by labelling this preparation with 58Fe and measuring day 14 erythrocyte 57Fe:58Fe., 14 days
Sponsor/Collaborators: Sponsor: Medical Research Council
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: EARLY_PHASE1
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Start Date: 2009-04
Completion Date: 2009-10
Results First Posted:
Last Update Posted: 2017-02-06
Locations: MRC Human Nutrition Research, Cambridge, Cambridgeshire, CB1 9NL, United Kingdom
URL: https://clinicaltrials.gov/show/NCT01991574